eLetters

47 e-Letters

published between 2018 and 2021

  • Response to ‘Delivering Community Emergency Medicine during the COVID-19 pandemic: the Physician Response Unit’

    We read with interest your experience of creating care pathways for patients in the out-of-hospital setting during the Covid-19 pandemic, in particular for those with palliative care needs. The benefits of the Physician Response Unit (PRU) being tasked to end of life care related 999 calls, their enhanced level of assessment and management and the resulting reduction in inappropriate hospital admission is to be applauded. There is additionally a need to recognise the wider use of such care pathways, available pan London, that support palliative and end of life care (EoLC) patients accessing emergency care.

    In collaboration with hospice and palliative care teams the London Ambulance Service NHS Trust (LAS) has to date, created 19 EoLC appropriate care pathways. These offer our clinicians access to specialist advice, support with complex decision making and provide an alternative to Emergency Department (ED) conveyance. In the last 2.5 years we have undertaken an extensive programme to improve EoLC within the LAS; providing tailored education to augment our clinicians’ knowledge and confidence, creating guidance which includes medications and symptom management at the end of life and increasing clinician use of advance care plans. As a result we have seen a 15% increase in staff confidence and an 18% median reduction in ED conveyance for this patient group; most importantly more patients are being cared for in their place of choice and in line with their wishes....

    Show More
  • Consequences of the emergency response to COVID-19

    Dear Sir,

    Within their conclusion, Charlton et al recommend further research to understand patient behaviour toward seeking help during the pandemic. In response to this, we would like to highlight the findings of our work which address this. We undertook a mortality review of all deaths in Salford during the peak 7 weeks of the initial pandemic surge (522 deaths), looking at themes which, if addressed could result in reduced mortality in future waves. We reviewed all 111, 999, general practice and hospital contacts for all patients from the 1st March 2020, to ensure all help seeking behaviour and the system response was understood. We have summarised these here.
    We noted 60 cases where patients delayed seeking help. We were also concerned that patients who were advised to call 111 by their GP, and were offered advice, would only call back when seriously ill. “COVID phobia” was evident in a small number of cases, at its extreme, including refusal to attend hospital and subsequent death at home.
    Fewer than half of NHS 111 calls were answered during the review period. Of those that were answered, 46% resulted in advice to contact their GP. Of these, 5 were subsequently admitted to hospital later the same day. Indeed, despite the national directive to telephone 111 as the first point of contact, only 13% actually did. 81% of patients contacted their GP in the period prior to their death.
    However, a lack of early face to face assessments was identi...

    Show More
  • Interrater-variability in frailty screening using the Safety Management System (VMS).

     

    To the editor,

    In their article “Agreement and predictive value of the Rockwood Clinical Frailty Scale (CFS) at emergency department triage”, Shrier et al (1) nicely illustrate that the level of agreement between different health care professionals in obtaining the CFS at different clinical settings is weak. The CFS was rated for 8,568 patients over 65 years by the triage nurse at the emergency department (ED) and by the attending physician on admission on the ward. Both scores were compared using the Cohen’s kappa coefficient, which was  0.21 and therefore is considered weak (2). 
    We found similar results in our AmsterGEM study. The AmsterGEM study is an observational prospective cohort study that investigates the prognostic accuracy of frequently used frailty screening instruments (3). Patients aged over 70 years old attending the ED were screened with four screening instruments, including the Safety Management System (VMS) (4). The VMS consists of four geriatric domains, which are associated with functional decline: delirium, malnutrition, falls and ADL limitations (5,6). All Dutch hospitals have implemented the VMS screening instrument for hospitalized older patients. In a sub-analysis of our study, the VMS was applied on 173 hospitalized patients over 70 years old, at the ED by a research student and at admission by the attending nurse on the ward. The average age was 81.2 years old, 81 (47%) were male and 111 s...

    Show More
  • Could assay choice and sample storage explain the poor D-dimer sensitivity found by the DiPEP study?

    Having recently updated our Emergency Department guidelines for suspected PE in pregnancy, we read the secondary analysis of the DiPEP study with great interest.1 However, we were quite surprised at the poor overall D-dimer sensitivity. Only 66% (8/12) of PEs would have been identified based on the recommended positivity threshold of 400ng/ml. This is considerably lower than the pooled estimate of 97% (95% CI 96-98%) found by a recent meta-analysis evaluating D-dimer for PE, and largely explains the poor performance of the YEARS and Geneva algorithms in the DiPEP cohort.2

    This result does not seem to fit with the known physiology of pregnancy. We know that D-dimer levels increase throughout pregnancy, which should improve sensitivity and worsen specificity.3 To our knowledge there are no other studies demonstrating impaired sensitivity of D-dimer in pregnant vs. non-pregnant populations.

    The DiPEP authors note that most of the study participants had received anticoagulation before blood samples were taken, which can decrease D-dimer levels by up to 25% in the first 24 hours.1 They also note however, that this would be insufficient to explain all their false negative D-dimer results. Aside from random error, we wondered if anything else could explain the poor sensitivity.

    One feature of the DiPEP study that stood out to us was the D-dimer assay used. As a microplate ELISA assay, the Zymutest D-dimer should be very sensitive but we could not find any st...

    Show More
  • Identification of technical factors associated with first-pass success of intubation with C-MAC video laryngoscope in children

    To the Editor
    We have read with great interest the recent article of Miller et al1 determining the technical factors associated with first-pass success (FPS) during endotracheal intubation with C-MAC video laryngoscope (VL) in children. They showed that placement of the blade tip into the epiglottic vallecula regardless of blade types, adequate glottic view and locating the glottic opening within second quintile of video displayer were significantly associated with FPS. Given that paediatric airway management is a great challenge to emergency physicians and the benefits of videolaryngoscopy are often significant in airway management of emergency paediatric patients,2 their findings have potentially clinical implications. Other than limitations described by authors in discussion, however, we noted several methodological issues in their article on which we invited authors to comment.
    First, primary outcome of this study was FPS, which was defined as passage of C-MAC VL into the mouth with the intention of intubation that terminated with successful intubation at first attempt. As described by authors in introduction, however, C-MAC VL is an intubating device with ability to perform both direct and video laryngoscopy using same device. That is, the larynx can be seen either under direct vision or on a monitor when using C-MAC VL.3 This advantage of C-MAC VL makes it exceptionally useful for emergency intubation. For example, in the event of a failed video laryngosc...

    Show More
  • The Prognostic Value of the Quick Walk Test during COVID-19 Outbreaks: the Experience of the Fenice Network

    We read with great interest the study by Goodacre et al. [1], where post-exertion oxygen saturation adds modest prognostic information to clinical assessment of suspected COVID-19 in the ED.

    This is partially in contrast with the findings of our study [2], performed within the Fenice Network (Italian group for clinical research in Emergency Medicine). In consecutive ED patients with SpO2 ≥ 95%, the most promising version of a standardised quick walk test (QWT) yielded a sensitivity of 83.3% (95% confidence interval [CI] = 35.9% to 99.6%), and specificity of 93.4% (95% CI = 91.5% to 95.0%). The positive and negative predictive values (PPVs and NPVs) were 8.6% (95% CI = 2.9% to 19.0%) and 99.9% (95% CI = 99.3% to 100.0%).

    This difference is probably due to 3 factors:

    1. The test standardisation. In our case series, the test was standardised for all centres and consists of a 30-40 metres walk at the maximun possible speed for each patient. Conversely, in the study by Goodacre et al., exertion SpO2 was either recorded after different, not standardised, intentional tests or could have made opportunistically after a spontaneous patient’s effort. The latter condition is particularly worrisome for the purpose of a thorough assessment of the prognostic value of the post-exertion oxygen saturation.

    2. The outcome definition. Goodacre et al. considered patients who died or required respiratory, cardiovascular or renal support within 30 days after initial p...

    Show More
  • Training for Major Incidents-mind the (COVID) gap?

    Dear Editor,

    The collated experiences and lessons from recent Major Incidents experienced in the UK is now juxtaposed with the ‘new normal’ of the healthcare community and emergency services operating with the threat of COVID-19 and the associated considerations of PPE against Aerosol Generating Procedures.

    Emergency service personnel and hospital clinicians will have trained with ‘universal precautions’ and risk-specific personal protective equipment for Health Emergency Preparation Exercises (HEPE) previously. COVID-19 has resulted in wide-spread adoption of single-use coveralls and respiratory protective equipment (facemask and powered hoods) beyond the specialist responders who would have normally exercised for major incidents whilst operating with these.

    With a return to a new normality of service provision and emergency preparedness, the clinical and logistical challenges of operating in AGP PPE need to be factored into MI plans and future practical exercises across the emergency services and acute hospital care. These range from those issues at the operational level such as dynamic risk assessment, identification and communication between clinicians and commanders at scene, record keeping and identifying the need to use COVID PPE (or when no longer needed, keeping in mind its exertional toll) and don and doff areas with ancillary staff.

    Tactical issues include conveyance platforms and options for patients from scenes to hospital – some of...

    Show More
  • Telehealth impact pre-COVID

    There is no question that SARS-CoV-2 has dramatically increased the utilization of telehealth services in the US and elsewhere. However, the claim that telehealth was not a significant factor pre-COVID is simply not true. Here is the quote from the article: "Prior to the severe acute respiratory syndrome coronavirus 2 or COVID-19 pandemic, telehealth generally had little overall engagement in the US healthcare system."

    In 2009 during the H1N1 epidemic, Kaiser Permanente-Northern California's (KP-NCAL) appointment and advice call centers (AACC) scheduled 900,000 telehealth visits. In 2010 in my capacity as Clinical Director of the KP-NCAL Sacramento AACC I organized a regional program employing telehealth to address the after hours needs of adults. That program over the next 8 years averaged 50,000 encounters per year on nights and weekends and backed up an additional 200,000+ locally managed afterhours telehealth visits per year. 24% of the total encounters in KP-NCAL's Adult and Family Medicine departments by 3.8 million adults in 2017 were delivered through virtual telehealth. I would say these efforts definitely qualify as substantial "overall engagement".

  • Takotsubo cardiomyopathy-related cardiogenic shock might be a contraindication

    The use of Angiotensin II for cardiogenic shock(1) might be counterproductive in patients who have cardiogenic shock attributable to Takotsubo cardiomyopathy(TTC) characterised by left ventricular outflow tract(LVOT) obstruction. The following are the reasons justifying non-use of that treatment modality:-
    Angiotensin II induces catecholamine release(2), thereby potentially exacerbating the catecholamine surge which characterises TTC. This catecholamine surge is mimicked by exogenous administration of epinephrine, the latter well documented as a trigger for de novo TTC in 22 patients reviewed in the literature search by Madisa et al(2). In another literature review, dobutamine(also a catecholamine ) triggered the onset of TTC in 22 patients(3). A typical example of the latter was a 61 year old woman who developed chest pain at 70% of her age-predicted heart rate, when she was on a 40 mcg/min infusion of dobutamine. Her electrocardiogram(ECG) then showed inferolateral ST segment elevation. Transthoracic echocardiography showed severe akinesia of the apical, anteroseptal, and apicolateral segments at peak dobutamine infusion. Coronary angiography disclosed normal epicardial vasculature(5).
    When LVOT obstruction occurs in TTC it can give rise to severe hypotension, exemplified by a 60 year old woman with a nadir systolic blood pressure(SBP) of 80 mm Hg in association with a gradient of 58 mm Hg across the LVOT. After landiolol( a beta blocker) inf...

    Show More
  • Traffic lights for a storm?

    I enjoyed reading this article, however, the reference to a cytokine storm warrants clarification. An editorial in JAMA Internal Medicine doi:10.1001/jamainternmed.2020.3313 suggested little evidence for such a storm and this has been supported by more recent studies by Remy et al in JCI Insight (10.1172/jci.insight.140329) who demonstrated severe immunosuppression and Kox et al in JAMA (doi:10.1001/jama.2020.17052) who found multiple cytokines were reduced in severe COVID-19.

Pages